Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
1992 and citations therein)
Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity
The April 2026 FDA action removes them from the Category 2 restricted compounding list effective April 23, 2026, and the FDAs Pharmacy Compounding Advisory Committee will review their compounding eligibility under 503A at its July 23-24, 2026 meeting
Source: Mol Syst Biol
pad2-1 , cad2-1 , nrc1 and zir1 , showed reduced root growth under control conditions and a more severe AITC-triggered root inhibition than the WT
Conlon TM et al
US$ 27.73
US$ 24.38
US$ 26.29
US$ 27.47
US$ 23.25
US$ 23.11
US$ 24.11
US$ 24.20
US$ 23.14
US$ 28.57
